CoChat

Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression

Open access
Misera, Agata, Liśkiewicz, Paweł, Łoniewski, Igor, Skonieczna-Żydecka, Karolina, Samochowiec, Jerzy · 2021 · Pharmaceuticals

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

Abstract

Probiotics were shown to act positively on gut–brain axis signaling. We aimed to assess the effect of the administration of a new class of probiotics—psychobiotics—using data from individual psychometric scales, markers of the immune system and neuroactive metabolites. Medical databases were searched from database inception until 22 April 2021 for randomized clinical trials in clinically proven Major Depressive Disorder (MDD) patients treated with either probiotics or placebo reporting any psychometric score (PROSPERO registration number: CRD42021253024). Ten studies with 705 randomized participants and 603 analyzed were included. The mean age of individuals was 38.43 ± 12.1 years, predominantly women (n = 461, 76.45). The mean study duration was 48.8 ± 12.3 (range = 28–62) days. The dosage ranged between 1 × 109 to 2 × 1010 colony forming units (CFU)/day. We found that probiotics might alleviate symptoms of MDD; endpoint data (pooled scores): SMD = −0.292, 95%CI = −0.577 to −0.007, p < 0.044; change scores (BDI): SMD = −0.482, 95%CI = −0.854 to –0.109, p < 0.011; DM = −4.848, 95%CI = −8.559 to −1.137, p < 0.01. The therapy tended to be more effective with time of psychobiotic supplementation (coefficient = −0.12, SE = 0.06, Z = −1.84, p = 0.06) and in men (% of females: coefficient = 0.1, SE = 0.06, Z = 1.78, p = 0.07). Psychobiotics have great potential in the treatment of MDD. However, no specific strain/strains, dosage or duration of treatment can currently be recommended.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ph14100952

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Study flow chart. N/n = number of studies.
Figure 1 Study flow chart. N/n = number of studies.CC BY · PubMed Central
Figure 2 An effect size (random model), SDM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls). Q = 9.197, df(Q) = 5, p = 0.101, I2 = 45.632.
Figure 2 An effect size (random model), SDM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls). Q = 9.197, df(Q) = 5, p = 0.101, I2 = 45.632.CC BY · PubMed Central
Figure 3 An effect size (random model), SDM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls) subgroup analysis BDI: Q = 1.924, df(Q) = 2, p = 0.382, I-squared = 0.0; HAMD: Q = 6.761, df(Q) = 2, p = 0.034, I2 = 70.41.
Figure 3 An effect size (random model), SDM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls) subgroup analysis BDI: Q = 1.924, df(Q) = 2, p = 0.382, I-squared = 0.0; HAMD: Q = 6.761, df(Q) = 2, p = 0.034, I2 = 70.41.CC BY · PubMed Central
Figure 4 An effect size (random model), DM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls) subgroup analysis BDI: Q = 2.185, df(Q) = 2, p = 0.335, I-squared = 8.48; HAMD: Q = 5.399, df(Q) = 2, p = 0.067, I2 = 62.955.
Figure 4 An effect size (random model), DM, for depression symptoms in clinical scores in persons taking probiotics vs. placebos (controls) subgroup analysis BDI: Q = 2.185, df(Q) = 2, p = 0.335, I-squared = 8.48; HAMD: Q = 5.399, df(Q) = 2, p = 0.067, I2 = 62.955.CC BY · PubMed Central
Figure 5 Funnel plots for (A) SDM and (B) DM for the psychometric score at endpoint.
Figure 5 Funnel plots for (A) SDM and (B) DM for the psychometric score at endpoint.CC BY · PubMed Central
Figure 6 Regression for SDM on strains used in trials. References [26,30], Formula 1 [23,28], Formula 2 [21].
Figure 6 Regression for SDM on strains used in trials. References [26,30], Formula 1 [23,28], Formula 2 [21].CC BY · PubMed Central
Figure 7 Regression for DM on (A) duration of supplementation abs (B)% of females participating in the trial.
Figure 7 Regression for DM on (A) duration of supplementation abs (B)% of females participating in the trial.CC BY · PubMed Central
Figure 8 (A). An effect size (random model), SDM, for depression symptoms in BDI change score in persons taking probiotics vs. placebos (controls). Overall: Q = 0.019, df(Q) = 1, p = 0.891, I-squared = 0.00; (B). An effect size (random model), DM for depression symptoms in BDI change scores in persons taking probiotics vs. placebos (controls). Overall: Q = 0.08, df(Q) = 1, p = 0.77, I2 = 0.00.
Figure 8 (A). An effect size (random model), SDM, for depression symptoms in BDI change score in persons taking probiotics vs. placebos (controls). Overall: Q = 0.019, df(Q) = 1, p = 0.891, I-squared = 0.00; (B). An effect size (random model), DM for depression symptoms in BDI change scores in persons taking probiotics vs. placebos (controls). Overall: Q = 0.08, df(Q) = 1, p = 0.77, I2 = 0.00.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 49 references

Cited by

See all 35

Metadata

Authors
Misera, A., Liśkiewicz, P., Łoniewski, I., Skonieczna-Żydecka, K., & Samochowiec, J.
Affiliations
  • Pomeranian Medical University (PL)
  • Department of Biochemical Sciences, Pomeranian Medical University in Szczecin, Broniewskiego 24, 71-460 Szczecin, Poland
Venue
Pharmaceuticals
Publisher
MDPI AG
Published
2021-09-23
Volume
14
Issue
10
Pages
952
ISSN
1424-8247 (ISSN-L)
OpenAlex
W3200103522
Cited by
34
References
48
Citations by year
2026: 8 · 2025: 10 · 2024: 4 · 2023: 7 · 2022: 4
FWCI
0.34
Type
journal article
Language
en
Open access
Locations
  • Pharmaceuticals (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Keywords
psychobiotics, major depressive disorder, probiotics, gut-brain axis, depressive symptoms, inflammatory markers, immune system, neuroactive metabolites, treatment duration, sex differences

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression. https://app.cochat.ai/papers/10.3390/ph14100952
The paper
Misera, A., Liśkiewicz, P., Łoniewski, I., Skonieczna-Żydecka, K., & Samochowiec, J. (2021). Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression. Pharmaceuticals. https://doi.org/10.3390/ph14100952

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.